drugset / Trial / NCT02750293

The Effect of Vitamin D Supplementation on Cardiovascular Risk Factors

NCT02750293

Phase 3 Completed 411 enrolled University of Tromso
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Six-hundred subjects with vitamin D deficiency will be randomized to vitamin D 3000 IU per day versus placebo for 4 months, with effects on cardiovascular risk factors as main endpoint

Timeline

Start
2015-06
Primary completion
2017-08
Completion
2017-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 20000 iu

Indications